Apellis

Apellis is a global biopharmaceutical company that leverages courageous science and compassion to develop therapies that target the complement system. Apellis is committed to addressing the unmet medical needs of patients and healthcare professionals worldwide, with the goal of slowing progression of geographic atrophy.